Estrogen Receptor Positive Breast Cancer Terminated Phase 1 Trials for Letrozole (DB01006)

Also known as: Oestrogen receptor positive breast cancer

IndicationStatusPhase
DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01208441RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast CancerTreatment